mda mb (Genecopoeia)
Structured Review
Mda Mb, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 66 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/single+cell+expression+data/Human+cell+line+MDA-MB-231+stably+expressing+CRISPR+Cas9%2C+randomly+inserted%2C+single+clone/pm33239429-128-6-18
Average 94 stars, based on 66 article reviews
Images
Related Articles
Multiple Displacement Amplification:Article Title: A B7-H3–Targeted CD28 Bispecific Antibody Enhances the Activity of Anti–PD-1 and CD3 T-cell Engager Immunotherapies Article Snippet: HLA-A2 expression was measured as a surrogate for expression of the fusion proteins using a PE-labeled HLA-A2 antibody (BioLegend; 343306; RRID: AB_1877227; BB7.2), and B7-H3 expression was verified with a PE-labeled anti–human B7-H3 antibody; both were assessed using flow cytometry. .. To generate MDA-MB-231-pp65 cell lines, we transfected Article Title: Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B. Article Snippet: .. Article Title: Bio-responsive adhesive antibody delivery platform for immunotherapy and preparation method thereof Article Snippet: .. MDA-MB-231 human breast cancer cells (ATCC No. HTB-26), Article Title: Miro1 knockout inhibits mouse breast cancer tumorigenesis Article Snippet: .. Article Title: Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B Article Snippet: .. Transfection:Article Title: A B7-H3–Targeted CD28 Bispecific Antibody Enhances the Activity of Anti–PD-1 and CD3 T-cell Engager Immunotherapies Article Snippet: HLA-A2 expression was measured as a surrogate for expression of the fusion proteins using a PE-labeled HLA-A2 antibody (BioLegend; 343306; RRID: AB_1877227; BB7.2), and B7-H3 expression was verified with a PE-labeled anti–human B7-H3 antibody; both were assessed using flow cytometry. .. To generate MDA-MB-231-pp65 cell lines, we transfected Article Title: Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B. Article Snippet: .. Article Title: Miro1 knockout inhibits mouse breast cancer tumorigenesis Article Snippet: .. Article Title: Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B Article Snippet: .. Expressing:Article Title: Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B. Article Snippet: .. Article Title: Miro1 knockout inhibits mouse breast cancer tumorigenesis Article Snippet: .. Article Title: Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B Article Snippet: .. Control:Article Title: Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B. Article Snippet: .. Article Title: Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B Article Snippet: .. Luciferase:Article Title: Bio-responsive adhesive antibody delivery platform for immunotherapy and preparation method thereof Article Snippet: .. MDA-MB-231 human breast cancer cells (ATCC No. HTB-26), Incubation:Article Title: Bio-responsive adhesive antibody delivery platform for immunotherapy and preparation method thereof Article Snippet: .. MDA-MB-231 human breast cancer cells (ATCC No. HTB-26), Modification:Article Title: Bio-responsive adhesive antibody delivery platform for immunotherapy and preparation method thereof Article Snippet: .. MDA-MB-231 human breast cancer cells (ATCC No. HTB-26), shRNA:Article Title: Miro1 knockout inhibits mouse breast cancer tumorigenesis Article Snippet: .. Plasmid Preparation:Article Title: Miro1 knockout inhibits mouse breast cancer tumorigenesis Article Snippet: .. other:Article Title: Redirecting cytotoxic lymphocytes to breast cancer tumors via metabolite-sensing receptors Article Snippet: Human TruStain FcX (Fc receptor blocker) (Biolegend, 422302, 1:50) was used to minimize nonspecific binding of antibodies. |

